financetom
Business
financetom
/
Business
/
What's Going On With Nvidia's Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Nvidia's Stock?
Apr 26, 2024 10:33 AM

Nvidia Corporation ( NVDA ) shares are trading higher Friday. Several AI-related and chip stocks are rising following better-than-expected earnings from Microsoft Corporation ( MSFT ) and Meta Platforms, Inc. ( META ) increased its capex outlook. 

The Details:

Microsoft ( MSFT ) delivered better-than-expected first-quarter results Thursday, and Microsoft ( MSFT ) CEO Satya Nadella highlighted strong demand for the company's offerings, particularly in the field of artificial intelligence (AI).

Meta also reported strong first-quarter results this week and raised its capital expenditures outlook amid the company's increased efforts in AI.

Wedbush analyst Dan Ives expressed his excitement about the strong results from Microsoft ( MSFT ) and Alphabet, Inc. ( GOOG ) and emphasized the need for increased AI spending, as companies shift towards the "fourth industrial revolution."

Nvidia ( NVDA ) shares have gained nearly 15% over the past five days after dropping 10% last Friday in the stock's largest one-day loss since 2020. 

Related News: Snap Shares Soar On Better-Than-Expected Q1 Results, Daily Active User Growth, Q2 Revenue Guidance

Should I Sell My NVDA Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Shares of Nvidia ( NVDA ) have gained 214.76% year to date. This compares to the average annual return of 74.89%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Nvidia ( NVDA ) stock currently has an RSI of 46.67, indicating neutral conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

NVDA Price Action: According to Benzinga Pro, Nvidia ( NVDA ) shares are up 5.91% at $875.16 at the time of publication Friday.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Vodafone Says Disagree With CMA's Provisional Findings On Vodafone/Three Merger
BRIEF-Vodafone Says Disagree With CMA's Provisional Findings On Vodafone/Three Merger
Sep 14, 2024
Sept 13 (Reuters) - Vodafone Group PLC ( VOD ): * VODAFONE GROUP PLC ( VOD ) - VODAFONE ( VOD ) & THREE RESPONSE CMA PROVISIONAL FINDINGS * VODAFONE DISAGREE WITH CMA'S PROVISIONAL FINDINGS * VODAFONE ( VOD ) - LOOK FORWARD TO WORKING WITH CMA TO SECURE APPROVAL * VODAFONE ( VOD ) : DO NOT AGREE WITH...
Nvidia's stock market dominance fuels big swings in the S&P 500
Nvidia's stock market dominance fuels big swings in the S&P 500
Sep 14, 2024
NEW YORK (Reuters) -Nvidia's huge stock rally is still exerting an outsized influence over the S&P 500 index , reinforcing concerns that broader markets could be hurt if the chipmaking giant's fortunes turn. This year's 140% surge in shares of Nvidia, whose chips are seen as the gold standard in artificial intelligence applications, has accounted for about a quarter of...
MBX Biosciences Prices $163.2 Million IPO
MBX Biosciences Prices $163.2 Million IPO
Sep 14, 2024
03:57 AM EDT, 09/13/2024 (MT Newswires) -- MBX Biosciences (MBX) said late Thursday it priced its initial public offering of 10.2 million common shares at $16 per share for expected gross proceeds of $163.2 million. The company granted the underwriters a 30-day option to buy an additional about 1.5 million shares. The shares are expected to start trading on the...
BRIEF-James Flynn Reports 6.66% Stake In Singular Genomics Systems Inc As Of September 5 - SEC Filing
BRIEF-James Flynn Reports 6.66% Stake In Singular Genomics Systems Inc As Of September 5 - SEC Filing
Sep 14, 2024
Singular Genomics Systems Inc ( OMIC ): * JAMES FLYNN REPORTS 6.66% STAKE IN SINGULAR GENOMICS SYSTEMS INC AS OF SEPTEMBER 5 - SEC FILING * JAMES FLYNN - ON SEPT 5, DEERFIELD SUBMITTED NON-BINDING PROPOSAL TO SPECIAL COMMITTEE OF INDEPENDENT DIRECTORS OF SINGULAR GENOMICS SYSTEMS * JAMES FLYNN - PROPOSAL RELATES TO BUY ALL OUTSTANDING SHARES OF SINGULAR GENOMICS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved